Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inhalation of Ciclesonide for Patients With COVID-19: A Randomised Open Treatment Study (HALT COVID-19)

NCT04381364 is registered in ClinicalTrials.gov with Ola Blennow, MD, PhD as lead sponsor.

NCT NCT04381364
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04381364 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inhalation of Ciclesonide for Patients With COVID-19: A Randomised Open Treatment Study (HALT COVID-19)
Lead sponsor
Ola Blennow, MD, PhD
Phase
Phase 2
Overall status
Unknown status
Start date
May 29, 2020
Completion date
January 31, 2022
Enrollment
98 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, pneumonia, viral, sars-cov2